Today: 7 February 2026
Subscribe

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Tunbridge Wells taps wobble again: South East Water targets Jan 13 fix as MPs press for answers

Tunbridge Wells taps wobble again: South East Water targets Jan 13 fix as MPs press for answers

South East Water expects to restore full water supplies in Tunbridge Wells by Jan. 13 after burst pipes and Storm Goretti left some customers with intermittent service. MPs are pressing the company for clarity over its handling of last month’s longer outage, warning against misleading statements. The company says current water is safe and the latest disruption is unrelated to the previous boil notice.
10 January 2026
South32 stock near a 2026 high as dividend dates land; traders eye Feb 12 results

South32 stock near a 2026 high as dividend dates land; traders eye Feb 12 results

South32 shares closed up 1.1% at A$3.85, just below their 2026 high, after the miner released its 2026 calendar and set Feb. 12 for half-year results. The company confirmed a March 5 ex-dividend date and flagged a $60 million cost for the Mozal smelter shutdown in Mozambique. The S&P/ASX 200 slipped 0.03% as Rio Tinto fell 6.2%. Glencore shares surged over 10% on takeover talks with Rio Tinto.
10 January 2026
···
Westpac shares (ASX:WBC) in focus after bushfire relief package as rate outlook shifts

Westpac shares (ASX:WBC) in focus after bushfire relief package as rate outlook shifts

Westpac will offer repayment deferrals and short-term credit support to customers affected by Victorian bushfires as fires force evacuations and disrupt businesses. The bank’s shares closed at A$37.90 on Friday, down 0.29%, alongside broader losses in the sector. Traders await Australia’s quarterly CPI on Jan. 28 and the Reserve Bank’s rate decision on Feb. 3.
10 January 2026
Northern Star shares: ASX query puts NST costs and Super Pit repairs back in focus

Northern Star shares: ASX query puts NST costs and Super Pit repairs back in focus

Northern Star Resources said it cannot yet quantify the impact of weaker December-quarter gold sales on FY26 costs after a key crusher at its Kalgoorlie mine failed on Dec. 23 and was restored Jan. 5. Shares closed at A$24.72, up 0.49%. The company cut its FY26 production guidance last week and will update investors with quarterly results on Jan. 22.
10 January 2026
···
ANZ stock slips into weekend as rate nerves linger; CPI and RBA set next test

ANZ stock slips into weekend as rate nerves linger; CPI and RBA set next test

ANZ Group Holdings fell 0.6% to A$35.45 Friday, tracking declines across Australia’s major banks as investors awaited U.S. jobs data and local inflation figures. The Reserve Bank of Australia signaled it will watch fourth-quarter CPI, due Jan. 28, before its Feb. 3 policy meeting. ANZ shares traded between A$35.23 and A$35.82, with traders eyeing A$35.20–A$35.30 as key support.
10 January 2026
···
1 … 216 217 218 219 220 … 535

Stock Market Today

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

7 February 2026
Applied Digital Corporation shares jumped 25.52% Friday to $34.95, then slipped to $34.60 after hours. The company reported fiscal Q2 revenue up 250% to $126.6 million and signed leases for 600 MW of data center capacity in North Dakota. Applied Digital broke ground on a new 430‑MW campus in the southern U.S. in January. Financing includes a $100 million promissory note with 8% interest, paid in kind.
Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
Go toTop